Westlake sells Somatex to trade for $64m

Hologic, which specialises in women's health, said in a statement that the acquisition is intended to enhance its biopsy and breast health portfolio. Prior to the acquisition, Hologic already distributed Somatex's Tumark tissue market products in the US market.

Westlake acquired Somatex in November 2014 alongside a group of entrepreneurs via acquisition company E Med Solutions. The group wholly acquired the business, alongside the company's founder.

Westlake generally deploys equity tickets of €5-50m, with the option to invest larger tickets alongside co-investors. The GP does not invest via a fund structure, according to its website.

Company
Founded in 1992, Somatex develops, manufactures and distributes disposable implements for use in tumour diagnostics, biopsy and other interventional procedures. The company is headquartered in Berlin and is expected to generate revenues of $13m in 2020, according to a statement.

People
Westlake Partners – Henning von Oertzen, Daniel Mahnert-Lueg (partners).
Somatex Medical Technologies – Jörg Heise (managing director).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• DACH
• Healthcare
• Trade sale
• Germany